Fundz

Who to call at BioCryst Pharmaceuticals, and when

Fundz watches for the moments BioCryst Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day BioCryst Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioCryst Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioCryst Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

BioCryst Pharmaceuticals pivots to cost-saving partnerships and ends internal discovery programs.

Jun 29, 2026

Contract Type

partnership

DurhamBiotechnologyHealth CareTherapeutics

Description

BioCryst Pharmaceuticals is closing its Discovery Center of Excellence in Birmingham, Alabama, to focus on external innovation and cost-saving partnerships. This strategic evolution will allow the company to dedicate resources towards building a sustainable pipeline for rare diseases.

Quick answer

BioCryst Pharmaceuticals pivots to cost-saving partnerships and ends internal discovery programs. (June 29, 2026). BioCryst Pharmaceuticals is based in Durham, North Carolina, United States.

What agreement did BioCryst Pharmaceuticals announce on June 29, 2026?
BioCryst Pharmaceuticals is closing its Discovery Center of Excellence in Birmingham, Alabama, to focus on external innovation and cost-saving partnerships. This strategic evolution will allow the company to dedicate resources towards building a sustainable pipeline for rare diseases.
What does BioCryst Pharmaceuticals do?
BioCryst is focused on developing novel therapies for diseases with significant unmet needs.
Where is BioCryst Pharmaceuticals based?
BioCryst Pharmaceuticals is based in Durham, North Carolina, United States.

Source: Fundz verified event record.

Company Information

Company

BioCryst Pharmaceuticals

Location

4505 Emperor Boulevard

Durham, North Carolina, United States

About

BioCryst is focused on developing novel therapies for diseases with significant unmet needs. The company has already commercialized ORLADEYO® (berotralstat), a once-daily oral plasma kallikrein inhibitor, and continues to develop a pipeline of small-molecule and protein therapies.

Related People

Babar
Likely contact at this company
••••••••@••••••••

See Babar's verified email →

Carlos
Likely contact at this company
••••••••@••••••••

See Carlos's verified email →

Griffin
Likely contact at this company
••••••••@••••••••

See Griffin's verified email →

Mike
Likely contact at this company
••••••••@••••••••

See Mike's verified email →

Suzie
Likely contact at this company
••••••••@••••••••

See Suzie's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for BioCryst Pharmaceuticals's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

BioCryst Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.